Euda Health (NASDAQ: EUDA) terminates $10.0 million at-the-market share plan

Rhea-AI Filing Summary

Euda Health Holdings Limited reports that it has terminated its at-the-market equity offering program and the related At The Market Offering Agreement with Chardan Capital Markets, LLC. The program had previously allowed sales of ordinary shares with an aggregate offering price of up to $10.0 million, but this capacity had been reduced to zero and no ordinary shares were sold. All related prospectus supplements are also terminated as of the date of this supplement. The company’s ordinary shares trade on the NASDAQ Capital Market under the symbol EUDA, and the closing price was $15.30 on July 21, 2026.

Key Figures

Prior ATM capacity: $10.0 million aggregate offering price Share price: US$15.30 Registration number: 333-282723

3 metrics

Prior ATM capacity $10.0 million aggregate offering price Ordinary shares under at-the-market offering program

Share price US$15.30 Closing price of ordinary shares on July 21, 2026

Registration number 333-282723 SEC registration statement reference for the prospectus

Key Terms

at-the-market offering, prospectus supplement, NASDAQ Capital Market, aggregate offering price

4 terms

at-the-market offering financial

"an aggregate offering price of up to $10.0 million in an “at-the-market” offering"

An at-the-market offering is a method companies use to sell new shares of stock directly into the open market over time, rather than all at once. This allows them to raise money gradually, similar to selling small pieces of a product instead of a large batch. For investors, it means the company can access funding more flexibly, but it may also increase the supply of shares and influence the stock’s price.

prospectus supplement regulatory

"This prospectus supplement amends and supplements the prospectus"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

NASDAQ Capital Market market

"Our Ordinary Shares are listed on the NASDAQ Capital Market"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

aggregate offering price financial

"ordinary shares, having an aggregate offering price of up to $10.0 million"

The aggregate offering price is the total dollar amount that will be raised if all the securities in an offering are sold at the stated offering price, before fees or expenses are taken out. Investors use it to gauge the size of the fundraising and its potential effects—such as how much cash the company will get and how much existing ownership might be reduced—similar to totaling every item’s price in a shopping cart to see the full bill.

Offering Details

ATM

Offering

Offering Type ATM

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/22/2026 - 07:00 AM Accepted by SEC EDGAR 07/22/2026 - 07:00 AM Learn about SEC filing dates

FAQ

What did EUDA (EUDA) change regarding its at-the-market offering?

Euda Health terminated its at-the-market offering and the related At The Market Offering Agreement with Chardan Capital Markets, LLC. The program’s maximum $10.0 million capacity had already been reduced to zero before termination.

How many shares were sold under EUDA’s terminated ATM program?

Euda Health reports that no ordinary shares were sold under the At The Market Offering Agreement or the related prospectus supplements. The ATM program was first reduced to zero capacity and then terminated entirely.

What was the size of EUDA’s prior ATM capacity before termination?

The company had previously registered ordinary shares with an aggregate offering price of up to $10.0 million under an at-the-market offering program. A later supplement reduced this capacity to zero before the agreement was fully terminated.

Is EUDA currently able to sell stock under the terminated ATM agreement?

No. Euda Health has terminated the At The Market Offering Agreement and all related prospectus supplements, so it no longer has authority under that program to sell ordinary shares.

On which exchange does EUDA trade and what was the recent price?

Euda Health’s ordinary shares trade on the NASDAQ Capital Market under the symbol EUDA. The closing price of the ordinary shares was $15.30 on July 21, 2026.

Filed Pursuant to Rule 424(b)(5)

Registration No. 333-282723

PROSPECTUS SUPPLEMENT

(To Prospectus dated November 4, 2024)

EUDA HEALTH HOLDINGS LIMITED

This prospectus supplement (this “Supplement”) amends and supplements the prospectus dated November 4, 2024 (the “Base Prospectus”), as amended and supplemented by the Prospectus Supplement dated June 24, 2025, January 23, 2026, (collectively, the “Filed Prospectus Supplements”) and June 11, 2026 (the “June 2026 Prospectus Supplement”). This Supplement is qualified in its entirety by reference to the Base Prospectus, as amended and supplemented to date, except to the extent that the information herein amends or supersedes the information contained therein.

We filed the Filed Prospectus Supplements to register the offer and sale of shares of our ordinary shares, having an aggregate offering price of up to $10.0 million in an “at-the-market” offering (the “ATM Offering”) pursuant to the At The Market Offering Agreement, dated June 23, 2025 (the “ATM Agreement”), with Chardan Capital Markets, LLC (the “Manager”), and the June 2026 Prospectus Supplement to amend and supplement the information in the Filed Prospectus Supplements to suspend the ATM Offering and reduce the maximum aggregate offering price of our ordinary shares that may be offered and sold under the ATM Agreement to zero. As of the date of this Supplement, no ordinary shares have been sold under the ATM Agreement or the Filed Prospectus Supplements.

On June 5, 2026, we sent the Manager a notice to terminate the ATM Agreement and the ATM Offering. We are filing this prospectus supplement to report the termination of the ATM Agreement and the ATM Offering, and to terminate all related prospectus supplements effective as of the date hereof.

Our Ordinary Shares are listed on the NASDAQ Capital Market under the symbol “EUDA”. On July 21, 2026, the closing price of our Ordinary Shares on the Nasdaq Capital Market was US$15.30.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is July 22, 2026.